Vascular Events In Patients Undergoing Same-day Noncardiac Surgery (VALIANCE) Study (VALIANCE)

Vascular Events In Patients Undergoing Same-day Noncardiac Surgery (VALIANCE) Study - A Prospective Observational Cohort Study Evaluating Major Cardiovascular and Adverse Events in Patients Undergoing Elective Same-day Noncardiac Surgery

The proportion of noncardiac surgeries performed as same-day surgery is increasing worldwide, with more complex surgeries being performed on higher risk patients in the outpatient setting. Little is known on the risk factors, incidence and prognosis of patients undergoing same-day noncardiac surgery. The main objective of this study is to inform on the incidence and risk factors of cardiovascular and other adverse events after same-day surgery and to develop risk prediction tools to better inform on the risk and selection of patients undergoing same-day surgery.

Study Overview

Detailed Description

The VALIANCE Study is a 15,000 patient, multicentre, prospective observational cohort of adults undergoing elective same-day noncardiac surgery and who will be followed for 90 days after surgery. The primary objective of the study is to determine the incidence of major cardiovascular complications after same-day surgery. Patients will also be followed for the occurence of other adverse postoperative complications and determine their change in quality of life at 90 days after surgery. VALIANCE will inform on the risk factors for postoperative complications and allow to develop risk prediction tools to guide patient selection and risk stratification of patients undergoing same-day surgery. The study will also look at validating the use of the Duke Activity Status Index questionnaire, Clinical Frailty Scale, and the Revised Cardiac Risk Index. Postoperative pain will be evaluated using the Brief pain inventory score and quality of life using the EQ-5D-5L questionnaire.

Study Type

Observational

Enrollment (Estimated)

15000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Ontario
      • Hamilton, Ontario, Canada
        • Recruiting
        • Hamilton General Hospital
        • Contact:
          • John Harlock, MD, MSc
      • Hamilton, Ontario, Canada
        • Recruiting
        • Juravinski Hospital and Cancer Centre
        • Contact:
          • Ameen Patel, MD
      • Hamilton, Ontario, Canada
        • Recruiting
        • McMaster University Medical Centre
        • Contact:
          • Jessica Spence, MD, PhD
      • Hamilton, Ontario, Canada, L8N 4A6
        • Active, not recruiting
        • St-Joseph's Healthcare Hamilton
      • Toronto, Ontario, Canada, M5G 1X5
        • Recruiting
        • Mount Sinai Hospital
        • Contact:
          • James Khan, MD
      • Toronto, Ontario, Canada, M5T 2S8
        • Recruiting
        • Toronto Western Hospital
        • Contact:
          • Mandeep Singh, MBBS, MD, MSc, FRCPC
      • Toronto, Ontario, Canada
        • Recruiting
        • St-Micheal's Hospital
        • Contact:
          • Duminda M Wijeysundera, MD, PhD
    • Quebec
      • Montreal, Quebec, Canada, H2X0C1
        • Recruiting
        • Centre Hospitalier de l'Universite de Montreal (CHUM)
        • Contact:
        • Principal Investigator:
          • Emmanuelle Duceppe, MD, PhD
      • Sherbrooke, Quebec, Canada
        • Active, not recruiting
        • Centre Hospitalier Universitaire de Sherbrooke
      • Rotterdam, Netherlands
        • Recruiting
        • Maasstad Ziekenhuis Rotterdam
        • Contact:
          • Joseph Koopman, MD, PhD
      • Barcelona, Spain
        • Recruiting
        • Hospital Clinic Barcelona
        • Contact:
          • Eva Rivas, MD, PhD
    • North Carolina
      • Winston-Salem, North Carolina, United States, 27157
        • Recruiting
        • Wake Forest Baptist Medical Centre
        • Contact:
          • Ashish K Khanna, MD, MSc
    • Ohio
      • Cleveland, Ohio, United States, 44111
        • Recruiting
        • Cleveland Clinic Foundation Fairview Campus
        • Contact:
          • Sabry Ayad, MD, MBA
      • Cleveland, Ohio, United States, 44195
        • Recruiting
        • Cleveland Clinic Foundation Main Campus
        • Contact:
          • Daniel Sessler, MD
    • Texas
      • Houston, Texas, United States, 77030
        • Recruiting
        • MD Anderson Cancer Center
        • Contact:
          • Juan P Cata, MD
      • Houston, Texas, United States, 77030
        • Recruiting
        • Memorial Hermann Texas Medical Center UT Health
        • Contact:
          • Mehmet Alparslan Turan, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

All eligible adults undergoing elective same-day noncardiac surgery

Description

Inclusion Criteria:

  • 45-64 years of age with at least one risk factor, or ≥65 years of age;
  • undergoing elective noncardiac same-day surgery;
  • planned duration in the operating room 60 minutes or more;
  • provided written consent.

Exclusion Criteria:

  • intervention does not require the presence of an anesthesiologist;
  • procedure is performed by a nonsurgical specialty (e.g., gastroenterology, pneumology, radio-oncology or radiology);
  • intervention is an ophthalmologic procedure;
  • previously enrolled in the VALIANCE study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Unplanned healthcare utilization
Time Frame: 90 days
the number of patients who have at least one of the following: unplanned admission after surgery, unplanned outpatient visit, emergency room visit and rehospitalization after same-day surgery
90 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
unplanned admission
Time Frame: 90 days
the number of patients who have to be admitted to the hospital after undergoing a surgery planned as same-day
90 days
unplanned outpatient visit
Time Frame: 90 days
the number of patient who had a medical visit in an outpatient setting after undergoing same-day surgery
90 days
emergency room visit
Time Frame: 90 days
the number of patients who visited the emergency room without subsequent hospitalization after undergoing same-day surgery
90 days
re-hospitalization
Time Frame: 90 days
the number of patients who have to be readmitted to the hospital after being discharged home following their same-day surgery
90 days
major cardiovascular complications
Time Frame: 90 days
the number of patients who have at least one of the following: myocardial injury or infarction, non-fatal cardiac arrest, coronary revascularization, stroke, transient ischemic attack, new clinically significant arrythmia, congestive heart failure, unplanned postoperative admission for vascular reasons, emergency room visit for vascular reasons, rehospitalization for vascular reasons, and all-cause mortality
90 days
myocardial injury after noncardiac surgery (MINS)
Time Frame: 90 days
the number of patients who experience a MINS
90 days
myocardial infarction
Time Frame: 90 days
the number of patients who experience a myocardial infarction
90 days
non-fatal cardiac arrest
Time Frame: 90 days
the number of patients who experience a non-fatal cardiac arrest
90 days
coronary revascularization
Time Frame: 90 days
the number of patients who undergo coronary revascularization
90 days
stroke
Time Frame: 90 days
the number of patients who experience a stroke
90 days
transient ischemic attack
Time Frame: 90 days
the number of patients who experience a transient ischemic attack
90 days
new clinically important arrythmia
Time Frame: 90 days
the number of patients who experience a new clinically important arrythmia
90 days
acute congestive heart failure
Time Frame: 90 days
the number of patients who experience an acute congestive heart failure episode
90 days
deep vein thrombosis
Time Frame: 90 days
the number of patients who experience a deep vein thrombosis
90 days
pulmonary embolism
Time Frame: 90 days
the number of patients who experience a pulmonary embolism
90 days
major postoperative and life-threatening bleeding
Time Frame: 90 days
the number of patients who experience a major postoperative and/or life-threatening bleeding
90 days
postoperative infection
Time Frame: 90 days
the number of patients who experience a postoperative infection
90 days
acute kidney injury
Time Frame: 90 days
the number of patients who experience a acute kidney injury
90 days
quality of life score on the 5-level EQ-5D version (EQ-5D-5L) questionnaire
Time Frame: 90 days
score on the EQ-5D-5L questionnaire on 4 health profiles (level 1 to 5), overall self-rated health status (0-100 visual analogue scale), and EQ-5D-5L index value (0.01-0.99)
90 days
functional capacity score on the Duke Activity Status Index (DASI)
Time Frame: 90 days
change in the score on the Duke Activity Status Index (DASI) questionnaire (0 to 58.2 points)
90 days
frailty
Time Frame: 90 days
change in the level on the Clinical Frailty Scale (level 1 to 9)
90 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Emmanuelle Duceppe, MD, PhD, Centre Hospitalier de l'Universite de Montreal (CHUM)

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 17, 2021

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

April 1, 2027

Study Registration Dates

First Submitted

July 13, 2021

First Submitted That Met QC Criteria

July 13, 2021

First Posted (Actual)

July 22, 2021

Study Record Updates

Last Update Posted (Actual)

March 19, 2026

Last Update Submitted That Met QC Criteria

March 17, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myocardial Infarction

Subscribe